OrthoPediatrics Gains Expanded Indications for RESPONSE Scoliosis System
OrthoPediatrics was granted FDA 510(k) clearance to expand indications for the RESPONSE™ Scoliosis System to include neuromuscular implants. Mar 31, 2020
We've found 300 results
COVID-19 Orthopedic Company Updates
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19. Mar 24, 2020
Bone Therapeutics Gains Approval for Studies of OA Knee Pain Therapies
Bone Therapeutics received regulatory approvals for next studies of both of its lead therapeutic candidates to treat osteoarthritic knee pain. Mar 23, 2020
COVID-19 Impact: Procedure Deferrals Will Lead to Revenue Declines
After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments. Mar 20, 2020
AAOS Cancels 2020 Annual Meeting in Face of COVID-19 Concerns
The 2020 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) is canceled due to the ongoing spread of coronavirus. ORTHOWORLD wishes to reiterate our commitment to keep Members and subscribers apprised of the announcements to follow over the coming weeks. Mar 10, 2020
Omar Ishrak to Retire as CEO of Medtronic
Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice President of MDT's Restorative Therapies Group, will assume the newly-created role of Medtronic President in 4Q19 and succeed Ishrak as CEO next year. Aug 28, 2019
Foot and Ankle Implant Opportunities Lie in Design, Technique Improvements
The world of foot and ankle is vibrant and full of opportunity to solve real problems. Honesty in implant improvement must take place at the design stage. Foot and ankle has the trifecta of implants. Depending on the case, I need hardware, soft tissue reconstruction and a biologic enhancer. This is unique in orthopaedics, and the company that wins recognizes the problem to be solved in its totality and not just a piecemeal approach. Jan 25, 2019
Zimmer Biomet Names Ivan Tornos New Group President, Orthopedics
Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1. Oct 31, 2018
Zimmer Biomet Reports 1Q18 Orthopaedic Revenue
ORTHOWORLD estimates Zimmer Biomet 1Q18 orthopaedic revenue of US $1,856.6MM, +2.2% vs. 1Q17. May 03, 2018
Zimmer Biomet Appoints Bryan Hanson as President and CEO
Zimmer Biomet has appointed Mr. Bryan C. Hanson as President, Chief Executive Officer and member of its Board of Directors, effective immediately. Dec 19, 2017
